Microsoft Q1 points to ~16% GP growth in Q1

Crayon obtient la compétence AWS Generative AI

OSLO, Norvège--(BUSINESS WIRE)-- Crayon, un leader mondial de l’innovation et des services informatiques, a annoncé aujourd'hui avoir obtenu la . Cette spécialisation reconnaît Crayon comme un partenaire AWS qui aide les clients et le réseau de partenaires AWS (APN) à contribuer à l'essor des services, outils et infrastructures essentiels pour la mise en œuvre des technologies d’IA générative. L’obtention de la compétence AWS Generative AI différencie Crayon en tant que partenaire AWS ayant démontré son expertise technique et sa réussite client éprouvée, la société ayant consacré les 10 dern...

Crayon Achieves the AWS Generative AI Competency

OSLO, Norway--(BUSINESS WIRE)-- Crayon, a global leader in innovation and IT services, announced today that it has achieved the . This specialization recognizes Crayon as an AWS Partner that helps customers and the AWS Partner Network (APN) drive the advancement of services, tools, and infrastructure pivotal for implementing generative AI technologies. Achieving the AWS Generative AI Competency differentiates Crayon as an AWS Partner that has demonstrated technical proficiency and proven customer success as it has spent the last 10 years delivering applied AI projects across multiple industr...

Genmab (Buy, TP: DKK2630.00) - Epinkly off to a good start in 2024

Q1 sales beat our forecast and consensus due to higher product-related royalties and solid Epkinly sales, while the operating profit margin was softer than expected owing to higher opex. Genmab reiterated the 2024 guidance for sales of DKK18.7bn–20.5bn, opex of DKK12.4bn–13.4bn, and operating profit of DKK4.6bn–7.1bn. We expect a strong pipeline of news flow in 2024. We reiterate our BUY and DKK2,630 target price.

The weekly navigator

From the past week, we highlight: 1) we raised our target price on Latour to SEK285 (280), but reiterated our HOLD; 2) Kinnevik-owned Lunar raised SEK282m of new capital; and 3) we will host an investor lunch with Latour’s CEO Johan Hjertonsson at our Stockholm office next week.

Aker BP (Buy, TP: NOK290.00) - Capex concerns looming

While investor concerns appear tilted towards a near-term production decline, we are increasingly concerned that consensus FCF will face meaningful negative revisions, as capex assumptions beyond 2026 look far too low. For 2027–2030, our FCF estimates are ~40% below consensus. We reiterate our BUY, but have cut our target price to NOK290 (325) on a lower fair P/NAV.